Degenerative Disc Disease Market is Expected to Expand at a Healthy Growth Rate by 2030 Owing to the Initiative by Key Companies such as DiscGenics, Spinal Simplicity, Bone Therapeutics, and Several Others

Degenerative-Disc-Disease-Market

DelveInsight’s Degenerative Disc Disease Market Insights Report offers a detailed analysis of disease, its causes, symptoms, diagnostics modalities, and treatment options. The report also offers comprehensive insights into Degenerative Disc Disease market size, epidemiology, emerging therapies, market drivers, market barriers, ongoing clinical trials, key collaboration in the space, and major pharmaceutical companies actively involved in the therapeutics market. 

Some of the key highlights from the Degenerative Disc Disease Market Insights: 

  • As per the study conducted by Senglaub et al. 2018, 266 million individuals (3.63%) worldwide are diagnosed with lumbar degenerative spine disease (DSD) yearly and the highest estimated incidence was observed to be in Europe (5.7%; 5668 per 100 000).
  • In the United States, nearly 80% of adults experience at least one episode of low back pain during their lifetime, and 5% experience chronic problems. An understanding of degenerative disk disease is important for managing these patients. [Stephen Kishner et al. 2019].
  • As per the study of Loyola University Medical Center, females present more chronic pain conditions as compared to males (3:2) but the Degenerative Disc Disease prevalence is almost similar and Females are 1.38 times more likely to have cervical DDD.
  • Globally, some of the key companies in the Degenerative Disc Disease Market such as Benvenue Medical, Spinal Simplicity, DiscGenics, Mesoblast, SpinalCyte, BioRestorative Therapies, and Tetec are involved in developing therapies.
  • The expected launch of emerging Degenerative Disc Disease therapies such as IDCT, ALLOB, Minuteman Fusion Implant, and others would lead to a significant increase in the market size during the forecast period.
  • As per DelveInsight, the Degenerative disk Disease Market is expected to observe significant growth in upcoming years due to the factors such as raising awareness of the disease, surge in funds for DDD clinical trials, and incremental healthcare spending across the world.

Learn more by requesting for sample @ Degenerative Disc Disease Market Landscape 

Degenerative Disc Disease: Overview 

Degenerative Disk Disease (DDD- osteochondrosis intervertebralis) is an age-related chronic condition that is characterized by progressive degeneration of the intervertebral discs. As per the WHO (2018), low back pain is one of the most prevalent problems in industrialized countries with the prevalence ranging from 60% to 90% and the top global cause of years lived with disability. There are a number of contributors to low back pain, one of which is DDD of the spine. Similarly, according to the study conducted by Dariusz Mydlarz et al. (2012), the estimated Degenerative Disc Disease prevalence in the general population range from 3 to 56 percent.

For more insights into Disease, causes, and treatment, reach out @ Degenerative Disc Disease Treatment Landscape 

Degenerative Disc Disease Epidemiology Segmentation
The Degenerative Disc Disease Market report proffers epidemiological analysis for the study period 2017-30 in the 7MM segmented into:

  • Diagnosed and Treatable Population of Degenerative Disk Disease
  • Total Prevalent Cases of Degenerative Disk Disease
  • Gender-specific Prevalent Pool of Degenerative Disk Disease
  • Disk Degeneration prevalence by spinal regions
  • Age-specific Prevalent Pool of Degenerative Disk Disease

Visit for more @ Degenerative Disc Disease Epidemiological Insights 

Degenerative Disc Disease Market
Currently, the Degenerative Disc Disease therapeutics approaches include physical therapy, chiropractic manipulative therapy, osteopathic manipulation, anti-inflammatory medications (such as non-steroidal anti-inflammatory drugs (NSAIDs)), and/or spinal injections, epidural steroid injections that can provide pain relief. If these more moderate approaches fail to alleviate symptoms, in some cases surgery is also conducted.

Several companies are focusing on modalities that aim to reverse the degenerative cascade through the use of biologics and gene modification. The ongoing research and development (R&D) activities and the emerging therapies for the Degenerative Disc Disease pipeline bring a positive ray of hope for potential treatment options in the market in the upcoming years. With the launch of the emerging therapies, the current treatment scenario is expected to observe a positive shift in the market for a study period.

Degenerative Disc Disease Pipeline Therapies and Key Companies

  • IDCT – DiscGenics 
  • Minuteman Fusion Implant – Spinal Simplicity
  • ALLOB – Bone Therapeutics

For more information, visit Degenerative Disc Disease Market Analysis, Patient Pool, and Emerging Therapies 

Degenerative Disc Disease Market Drivers

  • Improvement in diagnosis methodologies 
  • Increasing advances in regenerative medicine 
  • Incremental healthcare spending across the world

Scope of the Report

  • 11 Years Forecast
  • 7MM Coverage 
  • Descriptive overview of Degenerative Disc Disease, covering causes, signs and symptoms, pathophysiology, diagnosis, and currently available therapies
  • Comprehensive insight into Degenerative Disc Disease epidemiology and treatment in the 7MM
  • Current and emerging therapies for Degenerative Disc Disease 
  • Degenerative Disc Disease market drivers and barriers 

Key Questions Answered in the Report

  • What was the Degenerative Disc Disease market share (%) distribution in 2017 and how it would look like in 2030?
  • What would be the Degenerative Disc Disease total market size as well as market size by therapies across the 7MM during the forecast period (2017-2030)?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest Degenerative Disc Disease market size during the forecast period (2017-2030)?
  • At what CAGR, the Degenerative Disc Disease market is expected to grow in 7MM during the forecast period (2017-2030)?

Get in touch with our Business executive @ Degenerative Disc Disease Market Landscape Analysis 

Table of Contents 

1

Key Insights

2

Report Introduction

3

Competitive Intelligence Analysis for Degenerative Disc Disease

4

Degenerative Disc Disease Market Overview at a Glance

5

Executive Summary of Degenerative Disc Disease

6

Degenerative Disc Disease Epidemiology and Market Methodology

7

Degenerative Disc Disease Epidemiology and Patient Population

8

Degenerative Disc Disease Patient Journey

9

Treatment Algorithm, Current Treatment, and Medical Practices

10

Key Endpoints in Degenerative Disc Disease Clinical Trials

11

Degenerative Disc Disease Marketed Therapies 

12

Degenerative Disc Disease Emerging Therapies

13

Degenerative Disc Disease: 7 Major Market Analysis

14

Attribute analysis

15

Access and Reimbursement Overview of Degenerative Disc Disease

16

KOL Reviews

17

Case Reports

18

Degenerative Disc Disease Market Drivers

19

Degenerative Disc Disease Market Barriers

20

SWOT Analysis

21

Disclaimer

22

DelveInsight Capabilities

23

About DelveInsight

Learn more about the report offerings @ Degenerative Disc Disease Market Outlook

Related Reports

Degenerative Disc Disease (DDD) Epidemiology Forecast
DelveInsight’s Degenerative Disc Disease (DDD) Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Degenerative Disc Disease (DDD) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan

Degenerative Disc Disease Pipeline Insights
Degenerative Disc Disease Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Degenerative Disc Disease market.

Global Kinase Inhibitor in Autoimmune Diseases Market
DelveInsight’s “Global Kinase Inhibitor in Autoimmune Diseases  Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Global Kinase Inhibitor in Autoimmune Diseases market size, shares and trends analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

Muscle Atrophy/ Wasting Syndrome Market
DelveInsight’s “Muscle Atrophy/ Wasting Syndrome Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Muscle Atrophy/ Wasting Syndrome market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

Corneal Endothelial Dystrophy Market
DelveInsight’s “Corneal Endothelial Dystrophy Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Corneal Endothelial Dystrophy market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

Metrorrhagia Market Insight
DelveInsight’s “Metrorrhagia Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Metrorrhagia market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

Dysfunctional Uterine Bleeding Market
DelveInsight’s “Dysfunctional Uterine Bleeding Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Dysfunctional Uterine Bleeding market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

mRNA Vaccines and Therapeutics Market
DelveInsight’s ‘Global Messenger RNA (mRNA) based Vaccines and Therapeutics Market Insights, Epidemiology, and Market Forecast 2030’ report deliver an in-depth understanding of the mRNA-based Vaccines and Therapeutics, along with its historical and forecasted epidemiology and market trends in North America, Europe, Asia, and ROW (rest of the world).

Guillain-Barre Syndrome (GBS) Market
DelveInsight’s “Guillain-Barre Syndrome (GBS) Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Guillain-Barre Syndrome (GBS) market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

Healthcare Blogs – 

Get in touch with our Business executive for Competitive Intelligence Services

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Connect With Us at LinkedIn | Facebook | Twitter

Leave a Comment

Your email address will not be published. Required fields are marked *